Experience of successful treatment of a patient with chronic non-bacterial osteomyelitis (clinical case)

Abstract

BACKGROUND: Chronic nonbacterial osteomyelitis is a rare autoinflammatory bone disease with periods of relapses and remissions. No etiotropic therapy, diagnostic and treatment standards exist, patients are observed by rheumatologists, immunologists, and orthopedist. They receive symptomatic, anti-inflammatory treatment, broad-spectrum antibiotics, immunosuppressants to control inflammation, which helps to prevent new or to reduce existing pathological foci.

CLINICAL CASE DESCRIPTION: This article describes the effect of immune therapy and osteotropic treatment with zoledronic acid combination in a patient with chronic non-bacterial osteomyelitis. In a clinical observation involving comprehensive examination, including radiological (radiography, computed tomography and magnetic resonance imaging) and laboratory methods, a positive outcome was achieved using conservative methods of treatment in a patient with chronic non-bacterial sternum osteomyelitis.

CONCLUSION: Thus, a combination of bisphosphonates and immunotherapy may be promising in the treatment of chronic non-bacterial osteomyelitis. However, it is unknown as to how long the remission will last and what treatment program is necessary for the final disease resolution.

Keywords

chronic non-bacterial osteomyelitis / bisphosphonates / zoledronic acid / immunotherapy

References

[1] Zhao DY, McCann L, Hahn G, Hedrich CM. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun. 2021;4:100095. doi: 10.1016/j.jtauto.2021.100095

[2] Zhao D.Y., McCann L., Hahn G., Hedrich C.M. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) // J Transl Autoimmun. 2021. Vol. 4. N 100095. doi: 10.1016/j.jtauto.2021.100095 Дата публикации: 20.03.2021. Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040271/

[3] Buch K, Thuesen ACB, Brøns C, Schwarz P. Chronic Non-bacterial Osteomyelitis: A Review. Calcif Tissue Int. 2019;104(5):544–553. doi: 10.1007/s00223-018-0495-0

[4] Buch K., Thuesen A.C.B, Brøns C., Schwarz P. Chronic Non-bacterial Osteomyelitis: A Review // Calcif Tissue Int. 2019. Vol. 104, N 5. P. 544–553. doi: 10.1007/s00223-018-0495-0

[5] Girschick H, Finetti M, Orlando F, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry Rheumatology (Oxford). 2018;57(7):1203–1211. doi: 10.1093/rheumatology/key058

[6] Girschick H., Finetti M., Orlando F., et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry // Rheumatology (Oxford). 2018. Vol. 57, N 7. P. 1203–1211. doi: 10.1093/rheumatology/key058 [published correction appears in: Rheumatology (Oxford). 2018. Vol. 57, N 8. Р. 1504].

[7] Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14(2):130–141. doi: 10.1007/s11926-012-0239-5

[8] Ferguson P.J., Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis // Curr Rheumatol Rep. 2012. Vol. 14, N 2. P. 130–141. doi: 10.1007/s11926-012-0239-5

[9] Hedrich CM, Hofmann SR, Pablik J, et al. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47. doi: 10.1186/1546-0096-11-47

[10] Hedrich C.M., Hofmann S.R., Pablik J., et al. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO) // Pediatr Rheumatol Online J. 2013. Vol. 11, N 1. P. 47. doi: 10.1186/1546-0096-11-47 Дата публикации: 23.12.2013. Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881012/

[11] Hofmann SR, Schnabel A, Rösen-Wolff A, et al. Chronic Nonbacterial Osteomyelitis: Pathophysiological Concepts and Current Treatment Strategies. J Rheumatol. 2016;43(11):1956–1964. doi: 10.3899/jrheum.160256

[12] Hofmann S.R., Schnabel A., Rösen-Wolff A., et al. Chronic Nonbacterial Osteomyelitis: Pathophysiological Concepts and Current Treatment Strategies // J Rheumatol. 2016. Vol. 43, N 11. P. 1956–1964. doi: 10.3899/jrheum.160256

[13] Schnabel A, Range U, Hahn G, et al. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int. 2016;36(12):1737–1745. doi: 10.1007/s00296-016-3572-6

[14] Schnabel A., Range U., Hahn G., et al. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children // Rheumatol Int. 2016. Vol. 36, N 12. P. 1737–1745. doi: 10.1007/s00296-016-3572-6

[15] Berezhnyi AP, Ochkurenko AA. Conservative treatment of chronic recurrent multifocal osteomyelitis in children. N.N. Priorov Journal of Traumatology and Orthopedics. 1998;5(1):37–43. (In Russ). doi: 10.17816/vto104392

[16] Бережный А.П., Очкуренко А.А. Консервативное лечение хронического рецидивирующего многоочагового остеомиелита у детей // Вестник травматологии и ортопедии им. Н.Н. Приорова. 1998. Т. 5, № 1. С. 37–43. doi: 10.17816/vto104392

[17] Ochkurenko AA. On the issue of the effectiveness of hormonal and nonsteroidal anti-inflammatory therapy in the treatment of chronic recurrent multifocal osteomyelitis. Proceedings of the scientific session of the Russian Academy of Postgraduate Education dedicated to the 850th anniversary of Moscow. Issue 2. Moscow, 1997. P. 171–172. (In Russ).

[18] Очкуренко А.А. К вопросу об эффективности гормональной и нестероидной противовоспалительной терапии в лечении хронического рецидивирующего многоочагового остеомиелита // Материалы научной сессии РМАПО, посвященной 850-летию Москвы. Выпуск 2. Москва, 1997. С. 171–172.

[19] Petukhova V, Mushkin A, Kostik M. Bisphosphonate treatment in the bone disorders in children: a systematic review. Medical alliance. 2021:9(3):59–70. (In Russ). doi: 10.36422/23076348-2021-9-3-59-70

[20] Петухова В.В., Мушкин А.Ю., Костик М.М. Применение бисфосфонатов при костной патологии у детей (систематический обзор) // Медицинский альянс. 2021. Т. 9, № 3. С. 59–70. doi: 10.36422/23076348-2021-9-3-59-70

[21] Miettunen PM, Wei X, Kaura D, et al. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7:2. doi: 10.1186/1546-0096-7-2

[22] Miettunen P.M., Wei X., Kaura D., et al. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO) // Pediatr Rheumatol Online J. 2009. Vol. 7. N 2. doi: 10.1186/1546-0096-7-2 Дата публикации: 12.01.2009. Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631594/

[23] Morbach H, Stenzel M, Girschick HJ. Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis. Nat Clin Pract Rheumatol. 2008;4(11):570–571. doi: 10.1038/ncprheum0908

[24] Morbach H., Stenzel M., Girschick H.J. Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis // Nat Clin Pract Rheumatol. 2008. Vol. 4, N 11. P. 570–571. doi: 10.1038/ncprheum0908

[25] Yamashita K, Calderaro C, Labianca L, et al. Chronic recurrent multifocal osteomyelitis (CRMO) involving spine: A case report and literature review. J Orthop Sci. 2021;26(2):300–305. doi: 10.1016/j.jos.2018.06.015

[26] Yamashita K., Calderaro C., Labianca L., et al. Chronic recurrent multifocal osteomyelitis (CRMO) involving spine: A case report and literature review // J Orthop Sci. 2021. Vol. 26, N 2. P. 300–305. doi: 10.1016/j.jos.2018.06.015

[27] Zhao Y, Chauvin NA, Jaramillo D, Burnham JM. Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2015;42(7):1245–1251. doi: 10.3899/jrheum.141138

[28] Zhao Y., Chauvin N.A., Jaramillo D., Burnham J.M. Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial Osteomyelitis // J Rheumatol. 2015. Vol. 42, N 7. P. 1245–1251. doi: 10.3899/jrheum.141138

[29] Hofmann C, Wurm M, Schwarz T, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol. 2014;32(4):604–609.

[30] Hofmann C., Wurm M., Schwarz T., et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate // Clin Exp Rheumatol. 2014. Vol. 32, N 4. P. 604–609.

[31] Tsiskarashvili AV, Rodionova SS, Mironov SP, et al. Dynamics of bone tissue metabolism in the complex treatment of chronic posttraumatic osteomyelitis of long bones. N.N. Priorov Journal of Traumatology and Orthopedics. 2020;27(4):53–64. (In Russ). doi: 10.17816/vto52895

[32] Цискарашвили А.В., Родионова С.С., Миронов С.П., и др. Динамика метаболического состояния костной ткани при комплексном лечении хронического посттравматического остеомиелита длинных костей // Вестник травматологии и ортопедии им. Н.Н. Приорова. 2020. Т. 27, № 4. C. 53–64. doi: 10.17816/vto52895

[33] Hedrich CM, Morbach H, Reiser C, Girschick HJ. New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO. Curr Rheumatol Rep. 2020;22(9):52. doi: 10.1007/s11926-020-00928-1

[34] Hedrich C.M., Morbach H., Reiser C., Girschick H.J. New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO // Curr Rheumatol Rep. 2020. Vol. 22, N 9. P. 52. doi: 10.1007/s11926-020-00928-1 Дата публикации: 23.07.2020. Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378119/

[35] Hofmann SR, Kapplusch F, Mäbert K, Hedrich CM. The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)-a systematic review. Mol Cell Pediatr. 2017;4(1):7. doi: 10.1186/s40348-017-0073-y

[36] Hofmann S.R., Kapplusch F., Mäbert K., Hedrich C.M. The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)-a systematic review // Mol Cell Pediatr. 2017. Vol. 4, N 1. P. 7. doi: 10.1186/s40348-017-0073-y

[37] Hofmann SR, Kapplusch F, Girschick HJ, et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep. 2017;15(6):542–554. doi: 10.1007/s11914-017-0405-9

[38] Hofmann S.R., Kapplusch F., Girschick H.J., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment // Curr Osteoporos Rep. 2017. Vol. 15, N 6. P. 542–554. doi: 10.1007/s11914-017-0405-9

RIGHTS & PERMISSIONS

Eco-Vector